A cost-effectiveness analysis of South Africa's seasonal influenza vaccination programme.

ABSTRACT:

Background

Seasonal influenza imposes a significant health and economic burden in South Africa, particularly in populations vulnerable to severe consequences of influenza. This study assesses the cost-effectiveness of South Africa's seasonal influenza vaccination strategy, which involves vaccinating vulnerable populations with trivalent inactivated influenza vaccine (TIV) during routine facility visits. Vulnerable populations included in our analysis are persons aged ≥ 65 years; pregnant women; persons living with HIV/AIDS (PLWHA), persons of any age with underlying medical conditions (UMC) and children aged 6-59 months.

Method

We employed the World Health Organisation's (WHO) Cost Effectiveness Tool for Seasonal Influenza Vaccination (CETSIV), a decision tree model, to eval

SUBMITTER: Edoka I 

PROVIDER: S-EPMC7804372 | biostudies-literature | 2021 Jan

REPOSITORIES: biostudies-literature